Cargando…
Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study
(1) Background: Despite the existence of well-established, CSF-based biomarkers such as amyloid-β and phosphorylated-tau, the pathways involved in the pathophysiology of Alzheimer’s disease (AD) remain an active area of research. (2) Methods: We measured 3072 proteins in CSF samples of AD-biomarker...
Autores principales: | Kamalian, Aida, Ho, Sara G., Patel, Megha, Lewis, Alexandria, Bakker, Arnold, Albert, Marilyn, O’Brien, Richard J., Moghekar, Abhay, Lutz, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377001/ https://www.ncbi.nlm.nih.gov/pubmed/37509130 http://dx.doi.org/10.3390/biom13071094 |
Ejemplares similares
-
Phosphotyrosine profiling of human cerebrospinal fluid
por: Sathe, Gajanan, et al.
Publicado: (2018) -
Resting-State Functional Connectivity Is Associated With Cerebrospinal Fluid Levels of the Synaptic Protein NPTX2 in Non-demented Older Adults
por: Soldan, Anja, et al.
Publicado: (2019) -
Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015) -
Plasma and cerebrospinal fluid proteomic signatures of acutely sleep-deprived humans: an exploratory study
por: Vaquer-Alicea, Ana, et al.
Publicado: (2023) -
Con: Alzheimer's disease and circadian dysfunction: chicken or egg?
por: Moghekar, Abhay, et al.
Publicado: (2012)